BREYANZI
NDC 73153-900, Lisocabtagene maraleucel, kit, from Juno Therapeutics, Inc..
- Product NDC
- 73153-900
- Status
- Listed
- Labeler
- Juno Therapeutics, Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- CELLULAR THERAPY
- Marketing category
- BLA
- Application
- BLA125714
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73153-900 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73153-900-01 | 73153090001 | 1 KIT in 1 CARTON (73153-900-01) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-902-04) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-901-08) |
Linked data
RxNorm, label and prices
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=73153-900
Use it
Look up 73153-900 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73153-900 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73153-900. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.